A person’s gut microbiome appears to increase their risk of developing type 2 diabetes, researchers claim. Specific strains of gut microbes are more commonly found in people with type 2 diabetes, and these strains seem to heighten the risk of developing the metabolic disorder, they say. “We believe that changes in the gut microbiome cause…  read on >  read on >

A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests. Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compared to a placebo, researchers found. On a 30-point depression scale, people taking the ketamine pill improved…  read on >  read on >

A lonely middle and old age could bring higher odds for a stroke, new data suggests. A 12-year study of people over 50 found that those who experienced chronic loneliness were 56% more likely to have a stroke, versus those who said they weren’t lonely. “Loneliness is increasingly considered a major public health issue. Our…  read on >  read on >

Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin. But study results show that dropping pounds can improve a person’s odds…  read on >  read on >

A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce the progression of diabetic retinopathy by 27% compared to placebo. The findings were…  read on >  read on >

An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial results show. Seven out of 12 patients no longer needed daily insulin shots after receiving a full dose of the gene therapy, dubbed VX-800, researchers reported Friday at the American Diabetes Association’s annual meeting…  read on >  read on >